Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab As the Upfront Treatment in Patients with Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS)
JOURNAL OF CLINICAL ONCOLOGY（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined